Item
VIVAPUR 101 (V 101 NF)
"Microcrystalline Cellulose (MCC) is derived from 100% plant based, highly purified sources.
This non-caloric, insoluble fiber offers a variety of unique product characteristics."
Microcrystalline Cellulose
Food Ingredient
Attributes
- Gluten-free
- Halal
- Ingredient declaration
- Kosher
- PHO-free
- Ready-to-Eat (RTE)
- Vegan
- Non-GMO
Locations
Location name | Address |
---|---|
J. Rettenmaier USA LP - JRS Pharma LP | 725 41st Drive SW Cedar Rapids, IA 52404 |
Microcellulose Weißenborn GmbH & Co KG | Freiberger Straße 7 Weißenborn/Erzgeb., Unknown 09600 DEU |
Documents
Type | Location | File name | Effective | Expiration |
---|---|---|---|---|
Allergens | Microcellulose Weißenborn GmbH & Co KG | Allergens.pdf | 2/1/2024 | 1/31/2026 |
Allergens | J. Rettenmaier USA LP - JRS Pharma LP | Allergens.pdf | 4/15/2024 | 4/15/2026 |
Country of Origin | J. Rettenmaier USA LP - JRS Pharma LP | Country of Origin.pdf | 11/1/2024 | 11/1/2027 |
Product Specification Sheet | Microcellulose Weißenborn GmbH & Co KG | FOOD_TDS_VIVAPUR_101_en.pdf | 11/1/2022 | 10/31/2025 |
HARPC Food Safety Plan (Item) | J. Rettenmaier USA LP - JRS Pharma LP | FSMA Compliance Statement-9858-10 (2).pdf | 10/4/2023 | 10/3/2026 |
FSVP Assessment Form | J. Rettenmaier USA LP - JRS Pharma LP | FSVP Assessment Form.pdf | 9/17/2024 | 9/17/2025 |
Phthalate Esters Letter | J. Rettenmaier USA LP - JRS Pharma LP | General Phthalates Statement-2955-12.pdf | 6/19/2023 | 6/18/2024 |
HACCP Process Flow Diagram | Microcellulose Weißenborn GmbH & Co KG | HACCP Process flow Vivapur.pdf | 11/11/2024 | 11/11/2026 |
HACCP | J. Rettenmaier USA LP - JRS Pharma LP | HACCP Statement- JRS USA-2023-11.pdf | 9/21/2023 | 9/20/2026 |
Halal | J. Rettenmaier USA LP - JRS Pharma LP | Halal Pharma (MCCII) - 8.31.2025.pdf | 8/16/2024 | 8/31/2025 |
Item Questionnaire | J. Rettenmaier USA LP - JRS Pharma LP | Item Questionnaire.pdf | 11/1/2024 | 11/1/2027 |
Kosher | J. Rettenmaier USA LP - JRS Pharma LP | Kosher Vivapur - 8.31.2025.pdf | 8/16/2024 | 8/31/2025 |
Lot Code | J. Rettenmaier USA LP - JRS Pharma LP | Lot Number Code Interpretation-2024-22.pdf | 8/16/2024 | 8/16/2027 |
National Bioengineered Food Disclosure Standard (Simplified) | J. Rettenmaier USA LP - JRS Pharma LP | National Bioengineered Food Disclosure Standard (Simplified).pdf | 11/1/2024 | 11/1/2027 |
Organic | J. Rettenmaier USA LP - JRS Pharma LP | NotApplicable_Organic.pdf | 7/28/2023 | 7/28/2024 |
Nutrition | Microcellulose Weißenborn GmbH & Co KG | Nutrition.pdf | 2/6/2023 | 2/5/2026 |
Nutrition | J. Rettenmaier USA LP - JRS Pharma LP | Nutrition.pdf | 11/4/2024 | 11/4/2027 |
Pesticide | J. Rettenmaier USA LP - JRS Pharma LP | PRI_MCC.pdf | 5/20/2021 | 5/20/2023 |
Heavy Metal | J. Rettenmaier USA LP - JRS Pharma LP | PRI_MCC.pdf | 5/20/2021 | 5/20/2023 |
Animal Testing Statement | J. Rettenmaier USA LP - JRS Pharma LP | PRI_MCC.pdf | 10/13/2022 | 10/12/2024 |
BSE - TSE | J. Rettenmaier USA LP - JRS Pharma LP | PRI_MCC.pdf | 10/13/2022 | 10/12/2025 |
EtO Statement | J. Rettenmaier USA LP - JRS Pharma LP | PRI_MCC.pdf | 10/13/2022 | 10/12/2024 |
GRAS/NDI/ODI Statement | J. Rettenmaier USA LP - JRS Pharma LP | PRI_MCC.pdf | 10/13/2022 | 10/12/2025 |
Residual Statement | J. Rettenmaier USA LP - JRS Pharma LP | PRI_MCC.pdf | 10/13/2022 | 10/13/2023 |
WADA/NSF/NFL Statement | J. Rettenmaier USA LP - JRS Pharma LP | PRI_MCC.pdf | 10/13/2022 | 10/12/2024 |
Natural | J. Rettenmaier USA LP - JRS Pharma LP | PRI_MCC.pdf | 7/31/2023 | 7/30/2024 |
Melamine | J. Rettenmaier USA LP - JRS Pharma LP | PRI_VIVAPUR.pdf | 7/16/2024 | 7/16/2025 |
Gluten | J. Rettenmaier USA LP - JRS Pharma LP | PRI_VIVAPUR.pdf | 8/29/2024 | 8/29/2026 |
No Animal Ingredient Statement | J. Rettenmaier USA LP - JRS Pharma LP | PRI_VIVAPUR.pdf | 8/29/2024 | 8/29/2025 |
GMO | J. Rettenmaier USA LP - JRS Pharma LP | PRI_VIVAPUR.pdf | 9/13/2024 | 9/13/2026 |
Irradiation Status Statement | J. Rettenmaier USA LP - JRS Pharma LP | PRI_VIVAPUR.pdf | 9/13/2024 | 9/13/2026 |
Vegan/Vegetarian Statement | J. Rettenmaier USA LP - JRS Pharma LP | PRI_VIVAPUR.pdf | 9/13/2024 | 9/13/2026 |
Ingredient Statement | J. Rettenmaier USA LP - JRS Pharma LP | PRI_VIVAPUR.pdf | 10/4/2024 | 10/4/2027 |
HACCP Process Flow Diagram | J. Rettenmaier USA LP - JRS Pharma LP | Process Flow CR VIVAPUR MCC.pdf | 3/11/2024 | 3/11/2026 |
California Prop. 65 | J. Rettenmaier USA LP - JRS Pharma LP | Propositon 65 Statement- Vivapur- MCG, MCC, MC, HPMC-7726-13 (4).pdf | 9/12/2024 | 9/12/2026 |
Safety Data Sheet (SDS) | Microcellulose Weißenborn GmbH & Co KG | SDS_VIVAPUR_xx_en.pdf | 8/11/2023 | 8/10/2025 |
Safety Data Sheet (SDS) | J. Rettenmaier USA LP - JRS Pharma LP | SDS_VIVAPUR_xx_en.pdf | 6/10/2024 | 6/10/2027 |
Sewage Statement | J. Rettenmaier USA LP - JRS Pharma LP | Sewage Sludge Statement-34475-1 (2).pdf | 5/31/2024 | 5/31/2026 |
Product Specification Sheet | J. Rettenmaier USA LP - JRS Pharma LP | Spec_Vivapur 101_CCR_CN.pdf | 11/4/2024 | 11/4/2027 |
Shelf Life | J. Rettenmaier USA LP - JRS Pharma LP | Spec_Vivapur 101_CCR_CN.pdf | 11/4/2024 | 11/4/2027 |
Suitability Requirements | J. Rettenmaier USA LP - JRS Pharma LP | Suitability Requirements.pdf | 11/4/2024 | 11/4/2027 |
CoA Sample | J. Rettenmaier USA LP - JRS Pharma LP | V101C23D64.pdf | 9/1/2023 | 8/31/2025 |
Label Sample | J. Rettenmaier USA LP - JRS Pharma LP | Vivapur 101- Label.jpg | 8/29/2024 | 8/29/2025 |